• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec5
ADC Therapeutics Announces Latest Results from LOTIS-7 Trial
22:01
Nov11
RBC Analyst Maintains Buy Rating and Target Price for ADC Therapeutics
12:31
Nov10
ADC Therapeutics SA released FY2025 9 Months Earnings on November 10 Pre-Market EST, Actual Revenue: USD 58.3 M, Actual EPS: USD -1.1583
14:30
ADC Therapeutics SA released FY2025 Q3 earnings on November 10 Pre-Market EST, actual revenue USD 16.43 M (forecast USD 16.79 M), actual EPS USD -0.3002 (forecast USD -0.3616)
14:30
Nov3
ADC Therapeutics SA to Release FY2025 Q3 Earnings on November 10, 2025 Pre-Market EST, Forecast Revenue USD 17.08 M, EPS USD -0.38
00:07
Oct13
ADC Therapeutics Unveils Expansion Plan for ZYNLONTA
11:54

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 16.43 M, Net Income -40.97 M, EPS -0.3002

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 18.84 M, Net Income -56.65 M, EPS -0.498

May14
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 23.03 M, Net Income -38.6 M, EPS -0.36

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More